{"title":"What cannabis sales data can and cannot tell us about young adult risk: a critical commentary on retail trends and clinical practice.","authors":"Nichola Walker","doi":"10.1080/10550887.2026.2759627","DOIUrl":"https://doi.org/10.1080/10550887.2026.2759627","url":null,"abstract":"<p><strong>Background: </strong>Cannabis retail sales data from legalized markets provide a valuable but incomplete view of young adult consumption patterns. Recent analyses of California's commercial cannabis transactions show that, although flower accounts for the largest share of spending, young adults allocate a greater proportion of cannabis expenditure to vapor pens and concentrates than older adults. These trends raise important clinical and public health concerns.</p><p><strong>Methods: </strong>This commentary critically evaluates the strengths and limitations of retail analytics using established appraisal frameworks and considers the implications for clinical assessment, harm reduction, and policy development.</p><p><strong>Results: </strong>Retail datasets have inherent limitations that restrict their usefulness as indicators of individual risk. Transaction logs cannot capture frequency of use, dosage, motivations, psychosocial influences, or associated harms, and they exclude illicit market activity, which represents a substantial proportion of young adult consumption.</p><p><strong>Conclusions: </strong>Retail data should be interpreted as macro-level indicators rather than direct proxies for personal use. Effective risk assessment requires integrating commercial analytics with qualitative insight, epidemiological surveillance, and updated clinical screening approaches that reflect modern high-potency cannabis modalities. The commentary also considers how these findings translate to international contexts, including the United Kingdom, where unregulated markets and product mislabeling present additional challenges for frontline practitioners.</p>","PeriodicalId":47493,"journal":{"name":"Journal of Addictive Diseases","volume":" ","pages":"1-4"},"PeriodicalIF":1.7,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149411739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Impact of a preadmission consultation on inpatient treatment adherence among patients with substance use disorders: a retrospective cohort study.","authors":"Eva Staub, Pierre Cole, Matthieu Hein","doi":"10.1080/10550887.2026.2748930","DOIUrl":"https://doi.org/10.1080/10550887.2026.2748930","url":null,"abstract":"<p><strong>Background: </strong>Substance use disorders are associated with poor adherence and premature discharge. Preadmission consultations aim to improve engagement before inpatient detoxification, yet their impact remains undocumented.</p><p><strong>Objectives: </strong>To evaluate the impact of a preadmission consultation on inpatient adherence and identify associated factors.</p><p><strong>Methods: </strong>Retrospective single-center study of two cohorts hospitalized at the Centre Hospitalier Universitaire (CHU) Tivoli (Belgium): control group (<i>n</i> = 224, February 2021-February 2022) and preadmission group (<i>n</i> = 149, May 2023-May 2024). Four adherence indicators: discharge against medical advice, involuntary discharge, post-detoxification transfer, and length of stay. Secondary analyses examined substance type, comorbidities, housing, employment, age, and prior detoxification.</p><p><strong>Results: </strong>The preadmission group was more frequently male (75.2% vs. 63.0%, <i>p</i> = 0.013), homeless (22.8% vs. 10.7%, <i>p</i> = 0.002), and had higher rates of crack cocaine (31.0% vs. 8.9%, <i>p</i> < 0.001) and polysubstance use (49.7% vs. 38.8%, <i>p</i> = 0.039). Post-treatment transfers (13.4% vs. 7.1%, <i>p</i> = 0.044), stays ≥20 days (47.0% vs. 34.4%, <i>p</i> = 0.015), and involuntary discharges (18.1% vs. 10.7%, <i>p</i> = 0.041) were more frequent in the preadmission group. Discharge against medical advice did not differ. Cocaine, cannabis, and polysubstance use predicted discharge against medical advice; cluster B personality disorder and cannabis use were associated with shorter stays.</p><p><strong>Conclusions: </strong>The preadmission consultation may support care pathways and post-detoxification transitions. However, results warrant caution: discharge against medical advice was unchanged, involuntary discharges increased, and the preadmission group was more clinically complex. Whether observed benefits reflect the intervention or selection bias is unclear. Prospective studies are needed.</p>","PeriodicalId":47493,"journal":{"name":"Journal of Addictive Diseases","volume":" ","pages":"1-9"},"PeriodicalIF":1.7,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149381131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sivashankari Boobalan, Hemalatha Soundararajan, Meignana Arumugham I
{"title":"Effectiveness of community-based tobacco cessation programs in promoting tobacco abstinence: a systematic review and meta-analysis.","authors":"Sivashankari Boobalan, Hemalatha Soundararajan, Meignana Arumugham I","doi":"10.1080/10550887.2026.2752352","DOIUrl":"https://doi.org/10.1080/10550887.2026.2752352","url":null,"abstract":"<p><strong>Background: </strong>Community-based tobacco cessation programs may improve access to cessation support, particularly among populations facing barriers to conventional healthcare services. This systematic review evaluated the effectiveness of community-based tobacco cessation programs in promoting tobacco abstinence and improving cessation-related outcomes.</p><p><strong>Methods: </strong>A systematic review was conducted according to PRISMA 2020 guidelines and registered in PROSPERO (CRD420261438491). PubMed, Scopus, Google Scholar, Cochrane Library, and the Virtual Health Library Regional Portal were searched for studies published from January 2016 to January 2026. Randomized and non-randomized interventional studies evaluating community-based tobacco cessation programs were eligible. Risk of bias was assessed using RoB 2 and ROBINS-I, and certainty of evidence was assessed using GRADE. The primary meta-analysis included randomized trials reporting biochemically validated tobacco abstinence at six months with sufficiently comparable intervention-comparator contrasts.</p><p><strong>Results: </strong>Of 20,546 records identified, 11 studies were included, comprising six randomized and five non-randomized studies. Two randomized trials were included in the primary meta-analysis. The pooled estimate suggested a higher relative risk of biochemically validated tobacco abstinence at six months, although the effect was not statistically significant (RR = 1.34, 95% CI: 0.90-1.98; <i>p</i> = 0.147; <i>I</i><sup>2</sup> = 35.2%). Other studies reported variable effects on abstinence and cessation-related outcomes. The certainty of evidence was low.</p><p><strong>Conclusion: </strong>Evidence for the effectiveness of community-based tobacco cessation programs remains uncertain. Larger randomized trials using standardized, biochemically validated outcomes and longer follow-up are needed.</p>","PeriodicalId":47493,"journal":{"name":"Journal of Addictive Diseases","volume":" ","pages":"1-17"},"PeriodicalIF":1.7,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149301100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Divya Hegde, Reni Thomas, Anu Kanjirakattumadom Narayananunni, Johnson-Pradeep R
{"title":"Experiences of Dehumanization among men with Severe Alcohol Use Disorder and their caregivers in South India: a qualitative study.","authors":"Divya Hegde, Reni Thomas, Anu Kanjirakattumadom Narayananunni, Johnson-Pradeep R","doi":"10.1080/10550887.2026.2747768","DOIUrl":"https://doi.org/10.1080/10550887.2026.2747768","url":null,"abstract":"<p><strong>Background: </strong>Dehumanization, including disrespect, humiliation, exclusion, and loss of autonomy, is increasingly recognized among individuals with substance use disorders. However, little is known about these experiences among individuals with Severe Alcohol Use Disorders and caregivers in India.</p><p><strong>Objective: </strong>To explore Dehumanization experiences among men with Severe Alcohol Use Disorders and caregivers in familial, social, and healthcare contexts.</p><p><strong>Methods: </strong>A qualitative descriptive study using directed content analysis was conducted with seven men with Severe Alcohol Use Disorders and six primary caregivers at a tertiary-care psychiatric inpatient unit in South India. Participants were recruited purposively. In-depth, semi-structured interviews were audio-recorded, transcribed verbatim, and analyzed using a framework-informed content analysis approach guided by Fontesse et al. (2019). Reporting followed Standards for Reporting Qualitative Research guidelines.</p><p><strong>Results: </strong>Eight major themes were organized into three conceptual domains: (1) manifestations and contexts of Dehumanization, encompassing interpersonal, social, and healthcare experiences; (2) consequences and temporal dimensions of Dehumanization; and (3) empowerment and protective processes that may facilitate rehumanization and recovery. Participants described Dehumanization as contributing to emotional distress, social withdrawal, diminished self-worth, and maintenance of alcohol use, while compassionate family and healthcare support promoted hope and recovery.</p><p><strong>Conclusions: </strong>Dehumanization among persons with Severe Alcohol Use Disorders extends beyond stigma and adversely affects recovery, treatment engagement, and caregiver well-being. Person-centered, recovery-oriented, and rights-based interventions addressing stigma and relational trauma may improve outcomes for individuals with Severe Alcohol Use Disorders and their families.</p>","PeriodicalId":47493,"journal":{"name":"Journal of Addictive Diseases","volume":" ","pages":"1-10"},"PeriodicalIF":1.7,"publicationDate":"2026-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149301184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Dakota T May, Akbar Ali, Christopher E Potts, Shivam Gandhi, Robert Carter, Rajan Lamichhane, Mariam Ghafoor, Usman Alizai
{"title":"Urine drug screen co-positivity and the fentanyl testing gap among adult psychiatric emergency department encounters in West Virginia: a cross-sectional analysis.","authors":"Dakota T May, Akbar Ali, Christopher E Potts, Shivam Gandhi, Robert Carter, Rajan Lamichhane, Mariam Ghafoor, Usman Alizai","doi":"10.1080/10550887.2026.2748463","DOIUrl":"https://doi.org/10.1080/10550887.2026.2748463","url":null,"abstract":"<p><strong>Background: </strong>Traditional opiate immunoassays do not reliably detect fentanyl, and patterns of presumptive drug co-positivity in psychiatric emergency care remain poorly characterized.</p><p><strong>Objectives: </strong>To describe class-specific urine drug screen positivity, quantify co-positivity among explicitly co-tested encounters, and assess the fentanyl testing gap among adult psychiatric emergency department encounters at two hospitals in West Virginia.</p><p><strong>Methods: </strong>We retrospectively analyzed 1,091 adult psychiatric emergency department encounters at two West Virginia hospitals from October 2020 through December 2024. Testing was clinician-directed. Class-specific estimates used only encounters tested for each class. Six-core-class co-positivity was assessed among 281 complete-panel encounters; complete and incomplete panels were compared. Multivariable logistic regression evaluated fentanyl and amphetamine/methamphetamine co-positivity among 350 co-tested encounters.</p><p><strong>Results: </strong>Among tested encounters, tetrahydrocannabinol was positive in 214 of 513 (41.7%), amphetamine/methamphetamine in 203 of 509 (39.9%), and fentanyl in 146 of 519 (28.1%). Among complete-panel encounters, 128 of 281 (45.6%) were positive for at least two core classes. Substance-related chief complaints were more common among complete-panel encounters than among incomplete-panel encounters (73.3% versus 56.8%; <i>p</i> < .001). Among fentanyl-positive encounters co-tested for amphetamine/methamphetamine, 81 of 108 (75.0%) were also positive for amphetamine/methamphetamine. Amphetamine/methamphetamine positivity was associated with fentanyl positivity (adjusted odds ratio, 8.5; 95% confidence interval, 4.8-14.9). Among 118 fentanyl-positive encounters co-tested using the traditional opiate assay, 91 (77.1%) were opiate-screen-negative.</p><p><strong>Conclusions: </strong>Fentanyl and amphetamine/methamphetamine screens frequently overlapped in clinically selected subsets, and traditional opiate screening missed most fentanyl-positive screens. Psychiatric emergency services in fentanyl-affected regions should evaluate fentanyl-specific testing. Because immunoassays were presumptive and testing was nonprotocolized, findings represent screening yield, not confirmed exposure or population prevalence.</p>","PeriodicalId":47493,"journal":{"name":"Journal of Addictive Diseases","volume":" ","pages":"1-7"},"PeriodicalIF":1.7,"publicationDate":"2026-10-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149275525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effects of seven traditional Chinese sports on physiological outcomes in individuals receiving treatment for substance use disorder: a network meta-analysis of randomized controlled trials.","authors":"Jianqiang Guan, Xiaofei Zhang, Yuqi Wang, Jing Gao, Xin Gao","doi":"10.1080/10550887.2026.2746585","DOIUrl":"https://doi.org/10.1080/10550887.2026.2746585","url":null,"abstract":"<p><strong>Background: </strong>Substance use disorder is a major public health challenge, with physiological consequences, including dysregulated blood pressure, abnormal heart rate, and altered body composition, which increase the risk of cardiovascular disease and mortality. Physical exercise shows rehabilitation potential, but evidence-based guidance on optimal traditional Chinese exercise regimens is lacking.</p><p><strong>Objective: </strong>This network meta-analysis evaluated and ranked the comparative effects of seven traditional Chinese sports (Taiji Rouliqiu, combined Tai Chi and Qigong, 24-form Tai Chi, Baduanjin, Tai Chi rehabilitation exercise, shuttlecock, and Tai Chi Thirteen Postures Daoyin) on physiological outcomes in individuals with substance use disorder.</p><p><strong>Methods: </strong>Randomized controlled trials were searched from PubMed, Web of Science, CNKI, and VIP databases from inception to February 2026. A Bayesian network meta-analysis was performed, with treatment rankings assessed by surface under the cumulative ranking curve (SUCRA) values and consistency evaluated <i>via</i> node-splitting analysis.</p><p><strong>Results: </strong>Seventeen RCTs involving 1,133 participants were included. Combined Tai Chi and Qigong ranked highest for BMI (SUCRA = 92.4%), diastolic blood pressure (SUCRA = 73.8%), and resting heart rate (SUCRA = 82.9%). Tai Chi rehabilitation exercise ranked highest for systolic blood pressure (SUCRA = 66.3%), and Tai Chi Thirteen Postures Daoyin ranked highest for body fat percentage (SUCRA = 87.9%). No significant inconsistency was detected, and sensitivity analyses confirmed robustness.</p><p><strong>Conclusion: </strong>Combined Tai Chi and Qigong, Tai Chi rehabilitation exercise, and Tai Chi Thirteen Postures Daoyin emerged as the most promising interventions. These findings provide preliminary evidence for exercise-based rehabilitation strategies, though future head-to-head trials are needed to confirm the observed rankings.</p>","PeriodicalId":47493,"journal":{"name":"Journal of Addictive Diseases","volume":" ","pages":"1-14"},"PeriodicalIF":1.7,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149196780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Christine Ramdin, Jamey J Lister, Ellen Kurtzman, Sally Kuo, Stephanie Shiau, Howard Greller, Lewis S Nelson
{"title":"Substance use diagnoses among patients who present to federally run mental health facilities with co-morbid ADHD and bipolar disorder between 2013-2023: a national analysis using random forest methods.","authors":"Christine Ramdin, Jamey J Lister, Ellen Kurtzman, Sally Kuo, Stephanie Shiau, Howard Greller, Lewis S Nelson","doi":"10.1080/10550887.2026.2733227","DOIUrl":"https://doi.org/10.1080/10550887.2026.2733227","url":null,"abstract":"<p><strong>Background/objectives: </strong>Although substance use disorder is common in patients with attention deficit hyperactivity disorder or bipolar disorder, limited recent data exist for those with these co-occurring conditions. Our study analyzes recent trends and predictors of these diagnoses.</p><p><strong>Methods: </strong>We conducted a secondary analysis of 2013-2023 Mental Health Client-Level Data, identifying patients with co-morbid ADHD and bipolar disorder and their SUD prevalence. Joinpoint regression was used to analyze trends, and random forest models identified the most important predictors.</p><p><strong>Results: </strong>Between 2013 and 2023, 5,691 patients (0.008%) had comorbid ADHD and bipolar disorder, with rates increasing by 0.01% per year starting in 2016 (<i>p</i> < 0.0001). All patients had a documented SUD. Most patients were White (75.7%) and unemployed (1,284; 22.6%). The most common SUD diagnoses were 1) other unspecified substance dependence (665, 11.7%), 2) alcohol dependence (474, 8.3%), and 3) cannabis dependence (450, 7.9%). Key predictors included age, education, employment, and marital status.</p><p><strong>Conclusions: </strong>Our study identified the most common types of SUDs among those with co-morbid ADHD and bipolar disorder and associated risk factors. This will guide prevention and early intervention to reduce adverse outcomes.</p>","PeriodicalId":47493,"journal":{"name":"Journal of Addictive Diseases","volume":" ","pages":"1-12"},"PeriodicalIF":1.7,"publicationDate":"2026-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149196890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Thiago P Fernandes, Givago S Souza, Natanael A Santos
{"title":"Sequential dual-target tDCS for tobacco use disorder: A longitudinal pilot case series targeting craving and inhibitory control.","authors":"Thiago P Fernandes, Givago S Souza, Natanael A Santos","doi":"10.1080/10550887.2026.2676591","DOIUrl":"10.1080/10550887.2026.2676591","url":null,"abstract":"<p><strong>Background: </strong>Transcranial direct current stimulation (tDCS) is increasingly explored as an adjunctive intervention for Tobacco Use Disorder (TUD). Studies typically employ single-site stimulation protocols, and reported effects on craving and relapse have varied.</p><p><strong>Objective: </strong>To examine whether sequential dual-target tDCS could influence smoking behavior and relapse-relevant mechanisms in TUD.</p><p><strong>Methods: </strong>In this case series, three adults with TUD underwent a two-week sequential tDCS protocol targeting the left dorsolateral prefrontal cortex and pre-supplementary motor area. Assessments were conducted at baseline, post-intervention, and at 1- and 6-month follow-up characterize clinical, biological, and cognitive trajectories over time.</p><p><strong>Results: </strong>All cases showed reductions in cigarette consumption across the six-month follow-up, accompanied by decreases in biochemical exposure markers. Trajectories were heterogeneous across participants. Two individuals achieved abstinence at follow-up, while one maintained sustained reduction. Craving and withdrawal symptoms declined, and inhibitory control improved alongside reductions in exposure markers. The nicotine metabolite ratio remained stable across assessments, consistent with its role as an index of metabolic phenotype.</p><p><strong>Conclusions: </strong>Sequential dual-target tDCS was associated with longitudinal improvements in smoking behavior and relapse-related clinical and cognitive markers. These findings support further investigation of dual-target neuromodulation as a potential adjunctive strategy for smoking cessation.</p>","PeriodicalId":47493,"journal":{"name":"Journal of Addictive Diseases","volume":" ","pages":"568-578"},"PeriodicalIF":1.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148273342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A systematic review and meta-analysis exploring the recruitment hurdles and nonparticipation rate in noninvasive brain stimulation for addictive disorders.","authors":"Pinki Sevda, Priyanka Saha, Siddharth Sarkar, Rohit Verma, Naresh Nebhinani","doi":"10.1080/10550887.2025.2564446","DOIUrl":"10.1080/10550887.2025.2564446","url":null,"abstract":"<p><strong>Background: </strong>Substance use disorders (SUDs) are a growing public health concern with high relapse rates. Noninvasive brain stimulation techniques are emerging as potential adjunctive therapies; however, recruitment challenges persist in related clinical trials. To use systematic review and meta-analysis to determine the rate and reasons for nonparticipation in randomized controlled trials (RCTs) involving noninvasive brain stimulation for substance-related and addictive disorders.</p><p><strong>Materials and methods: </strong>Major databases (PubMed, CENTRAL, and Google Scholar) were searched from inception to January 2025 for RCTs of noninvasive brain stimulation and SUD. Of 3589 abstracts searched, 55 RCTs met the inclusion criteria. Eligible studies were peer-reviewed, published in English and examined any form of noninvasive brain stimulation in individuals with substance-related or behavioral addictions. Studies were required to report the number of individuals screened and ultimately randomized. Non-randomized studies, those involving invasive brain stimulation, were excluded.Following PRISMA guidelines, data were extracted independently by two reviewers, with discrepancies resolved by a third. Risk of bias (RoB) was assessed using the Cochrane RoB tool. Random-effects model was used for meta-analysis.</p><p><strong>Results: </strong>A total of 55 randomized trials were included which involved diverse SUDs and behavioral addictions. The pooled nonparticipation rate was 55.9% (95% CI: 45.9-65.8%; <i>I</i><sup>2</sup> = 99.56%, <i>p</i> < 0.001). Majority of the studies reported craving as an outcome measure. Key reasons included failure to meet inclusion criteria (reported in over 25 studies), refusal to participate due to anxiety or lack of motivation (≥15 studies), and logistical barriers such as travel or session frequency (≥10 studies).</p><p><strong>Conclusion: </strong>Nonparticipation in noninvasive brain stimulation trials for SUD are high, largely due to stringent eligibility criteria, procedural apprehension, and practical burdens faced by participants. Addressing these barriers through broader inclusion criteria, participant education, incentives, and flexible scheduling is essential to enhance recruitment, trial generalizability, and future clinical applicability of NIBS in addiction treatment.</p>","PeriodicalId":47493,"journal":{"name":"Journal of Addictive Diseases","volume":" ","pages":"459-478"},"PeriodicalIF":1.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145253297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Gopalkumar Rakesh, Thomas G Adams, Dylan H Ballard, Christopher J McLouth, Craig R Rush
{"title":"Theta burst stimulation (TBS) in methamphetamine use disorder: a meta-analysis and systematic review.","authors":"Gopalkumar Rakesh, Thomas G Adams, Dylan H Ballard, Christopher J McLouth, Craig R Rush","doi":"10.1080/10550887.2025.2541165","DOIUrl":"10.1080/10550887.2025.2541165","url":null,"abstract":"<p><p>Methamphetamine use disorder (MUD) currently lacks FDA-approved treatments. Previous studies involving transcranial magnetic stimulation (TMS) over the left dorsolateral prefrontal cortex (L.dlPFC) have shown promise in TMS's effectiveness at decreasing craving for methamphetamine. Theta burst stimulation (TBS), which includes intermittent (iTBS) and continuous (cTBS) protocols, is increasingly being used for substance use disorders, including MUD. Previous reviews of TMS in MUD performed subgroup meta-analyses of studies that delivered TBS in MUD. However, these meta-analyses included studies with overlapping participant cohorts, limiting their validity. To address this limitation, we reviewed randomized controlled trials (RCTs) using unique patient cohorts from PubMed/Medline, EMBASE, and Google Scholar until September 1, 2024, comparing the impact of TBS versus sham on cue-induced methamphetamine craving in patients with MUD. We performed a meta-analysis with four eligible RCTs that delivered iTBS. Results suggest iTBS was more effective in reducing cue-induced methamphetamine craving than sham iTBS (standardized mean difference [SMD] in change = 1.04; 95% CI [0.16, 1.92]). Two additional RCTs without sham control arms were reviewed, and one demonstrated a significant reduction in craving following accelerated iTBS. Future studies should examine whether neuroimaging-targeted iTBS can impact outcome measures other than craving, such as methamphetamine use, by measuring return to use. Exploring accelerated iTBS and cTBS for MUD, targeting alternative cortical sites such as the frontal pole, and studying their effects on relevant MUD biomarkers is also pertinent. This review demonstrates the effectiveness of TBS for MUD, emphasizing its potential to advance treatment options for MUD.</p>","PeriodicalId":47493,"journal":{"name":"Journal of Addictive Diseases","volume":" ","pages":"446-458"},"PeriodicalIF":1.7,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144776561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}